Expression of Fas/CD95 and Bcl-2 by primitive hematopoietic progenitors freshly isolated from human fetal liver

被引:60
作者
Barcena, A [1 ]
Park, SW [1 ]
Banapour, B [1 ]
Muench, MO [1 ]
Mechetner, E [1 ]
机构
[1] INGENEX INC, MENLO PK, CA USA
关键词
D O I
10.1182/blood.V88.6.2013.bloodjournal8862013
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The cell-surface expression and the functional status of the CD95/Fas antigen on primitive hematopoietic progenitors PHPs) freshly isolated from human fetal liver (FL) were studied. PHPs were phenotypically defined as CD34(++)CD38(-/+) cells. The most immature subfractions of PHPs, CD34(++)CD38(-) and CD34(++)CD38(+) FL cells, expressed CD95, whereas the more mature CD34(++)CD38(++) and CD34(+)CD38(++) FL cells displayed low CD95 expression. Combinations of cytokines, such as kit ligand (KL) + interleukin-3 or KL + granulocyte-macrophage colony-stimulating factor (GM-CSF) upregulated the expression of CD95 on PHPs upon in vitro culture. Tumor necrosis factor-alpha (TNF-alpha) and interferon-gamma (IFN-gamma) further increased the CD95 expression induced by KL + GM-CSF. The hematopoietic potential of sorted CD34(++)lineage (lin)(-) CD95(+) versus CD34(++)lin(-)CD95(-) FL cells was compared by colony-forming unit-culture (CFU-C) assays performed in serum-deprived medium. Lin(+) cells were composed of erythrocytes, monocytes, T cells, B cells, and natural killer cells. Our results indicated that both CD95(-) and CD95(+) subsets contained pluripotent progenitors, generating myeloid and erythroid progenitors. The functional status of CD95 and the effects of TNF-alpha and IFN-gamma, cytokines known to induce CD95-mediated apoptosis, were analyzed by incubation of PHPs in the presence of anti-CD95 monoclonal antibodies (MoAbs). The effect of anti-CD95 MoAbs was measured by viable cell counting, flow cytometry, and CFU-C assays. A decrease of CFU-C numbers was observed in the presence of anti-CD95 MoAbs and TNF-alpha and/or IFN-gamma. However, whereas growth factor deprivation induced apoptosis of PHPs, cross-linking of CD95 did not lead to apoptosis of PHPs measured by flow cytometry and viable cell counting. The correlation of increased intracytoplasmic levels of bcl-2 with high levels of cell-surface CD34 and the presence of CD95 on fresh FL cells suggests that bcl-2 may be involved in protecting against CD95-mediated apoptosis of FL PHPs. (C) 1996 by The American Society of Hematology.
引用
收藏
页码:2013 / 2025
页数:13
相关论文
共 61 条
[1]   FAS LIGAND MEDIATES ACTIVATION-INDUCED CELL-DEATH IN HUMAN T-LYMPHOCYTES [J].
ALDERSON, MR ;
TOUGH, TW ;
DAVISSMITH, T ;
BRADDY, S ;
FALK, B ;
SCHOOLEY, KA ;
GOODWIN, RG ;
SMITH, CA ;
RAMSDELL, F ;
LYNCH, DH .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 181 (01) :71-77
[2]   FAS TRANSDUCES ACTIVATION SIGNALS IN NORMAL HUMAN T-LYMPHOCYTES [J].
ALDERSON, MR ;
ARMITAGE, RJ ;
MARASKOVSKY, E ;
TOUGH, TW ;
ROUX, E ;
SCHOOLEY, K ;
RAMSDELL, F ;
LYNCH, DH .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 178 (06) :2231-2235
[3]   CLONING THE CHROMOSOMAL BREAKPOINT OF T(14-18) HUMAN LYMPHOMAS - CLUSTERING AROUND JH ON CHROMOSOME-14 AND NEAR A TRANSCRIPTIONAL UNIT ON 18 [J].
BAKHSHI, A ;
JENSEN, JP ;
GOLDMAN, P ;
WRIGHT, JJ ;
MCBRIDE, OW ;
EPSTEIN, AL ;
KORSMEYER, SJ .
CELL, 1985, 41 (03) :899-906
[4]   LYMPHOID AND MYELOID DIFFERENTIATION OF FETAL LIVER CD34+ LINEAGE(-) CELLS IN HUMAN THYMIC ORGAN-CULTURE [J].
BARCENA, A ;
GALY, AHM ;
PUNNONEN, J ;
MUENCH, MO ;
SCHOLS, D ;
RONCAROLO, MG ;
DEVRIES, JE ;
SPITS, H .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 180 (01) :123-132
[5]  
BARCENA A, 1993, BLOOD, V82, P3401
[6]   APOPTOSIS OF HUMAN HEMATOPOIETIC PROGENITOR CELLS INDUCED BY CROSS-LINKING OF SURFACE CD43, THE MAJOR SIALOGLYCOPROTEIN OF LEUKOCYTES [J].
BAZIL, V ;
BRANDT, J ;
TSUKAMOTO, A ;
HOFFMAN, R .
BLOOD, 1995, 86 (02) :502-511
[7]   A FLOW CYTOMETRIC METHOD USING HOECHST-33342 AND PROPIDIUM IODIDE FOR SIMULTANEOUS CELL-CYCLE ANALYSIS AND APOPTOSIS DETERMINATION IN UNFIXED CELLS [J].
BELLOC, F ;
DUMAIN, P ;
BOISSEAU, MR ;
JALLOUSTRE, C ;
REIFFERS, J ;
BERNARD, P ;
LACOMBE, F .
CYTOMETRY, 1994, 17 (01) :59-65
[8]  
BRACH MA, 1992, BLOOD, V80, P2920
[9]  
BRADLEY TR, 1979, BLOOD, V54, P1446
[10]  
BROXMEYER HE, 1986, J IMMUNOL, V136, P4487